Sotalol Hydrochloride Tablet
Product Images NDC 55154-8179

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 55154-8179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

17f2a6ca B6eb 4025 8ae0 A3d928f2fadc 00

Sotalol Hydrochloride Tablets USP 80 mg oral dosage form in a package containing 10 tablets. The label includes storage instructions (20° to 25°C), usage warnings, and distribution information by Cardinal Health and American Health Packaging.*

FDA Label Image

8a0b7575 7f90 9404 E053 2a95a90a002f

Sotalol Hydrochloride 80 mg oral tablet, white, elongated oval shaped with debossed markings. One side displays "APO" and the other side has a score line with "SO" on the left and "80" on the right. The tablet is manufactured by Cardinal Health 107, LLC.*

FDA Label Image

Figure 1

A graph showing the relationship between age in months (x-axis) and age factor (y-axis). The curve rises from approximately 0.18 at 0.1 months to 1.0 at about 24 months, indicating that the age factor gradually increases and reaches 1 for ages greater than 24 months.*

FDA Label Image

Figure 2

A Kaplan-Meier survival curve chart showing recurrence-free survival over 360 days for oral Sotalol at doses of 80 mg, 120 mg, and 160 mg compared to placebo. The chart includes p-values from a Log-Rank test for each dose versus placebo, illustrating differences in recurrence-free survival rates over time.*

FDA Label Image

Figure1.jpg (Image 01)

Chemical structure diagram depicting the molecular formula of Sotalol Hydrochloride, showing its characteristic functional groups and arrangement including a benzene ring attached to sulfonamide, hydroxyl, amine, and hydrochloride components.*

FDA Label Image

Image 02

A Kaplan-Meier survival curve showing recurrence-free survival over 180 days for Sotalol Hydrochloride AF compared to placebo. The vertical axis shows recurrence-free survival probability, and the horizontal axis denotes time in days. The graph includes a p-value of 0.002 for the log-rank test comparing oral Sotalol Hydrochloride to placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.